Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Blood|August 22, 2013
Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopeniaSylvain Audia, Maxime Samson, Matthieu Mahévas, et al.
Arthritis and Rheumatism|July 27, 2012
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesisMaxime Samson, Sylvain Audia, Jennifer Fraszczak, et al.
RMD Open|January 4, 2024
History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosisClaire De Moreuil, Elizabeth Diot, Christian Agard, et al.
Circulation|September 11, 2015
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 PatientsArsene Mekinian, Cloé Comarmond, Mathieu Resche-Rigon, et al.
Arthritis Care & Research|December 5, 2020
Osteitis in Systemic Sclerosis: A Nationwide Case-Control Retrospective StudyCyril Cosse, Solen Kernéis, Alain Lescoat, et al.
Plos Neglected Tropical Diseases|August 8, 2022
Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature reviewMarie-Fleur Durieux, Jean-Guillaume Lopez, Maher Banjari, et al.
Annals of the Rheumatic Diseases|March 15, 2018
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre studyGuillaume Moulis, Grégory Pugnet, Nathalie Costedoat-Chalumeau, et al.
Rheumatology (Oxford, England)|August 7, 2021
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patientsArsène Mekinian, Lucie Biard, Lorenzo Dagna, et al.
RMD Open|June 15, 2023
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective studyArsène Mekinian, Lucie Biard, Dagna Lorenzo, et al.
Pageof 4